First Analysis Comments on Safeguard Scientifics, Inc.’s Q2 2018 Earnings (SFE)

Safeguard Scientifics, Inc. (NYSE:SFE) – Investment analysts at First Analysis issued their Q2 2018 earnings per share estimates for shares of Safeguard Scientifics in a note issued to investors on Friday. First Analysis analyst J. Macdonald anticipates that the asset manager will post earnings of ($1.09) per share for the quarter.

Several other analysts have also recently issued reports on the company. ValuEngine cut Safeguard Scientifics from a “sell” rating to a “strong sell” rating in a research report on Tuesday, May 16th. Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a research note on Thursday, May 4th. Finally, BidaskClub raised Safeguard Scientifics from a “hold” rating to a “buy” rating in a research note on Thursday, July 13th.

ILLEGAL ACTIVITY WARNING: “First Analysis Comments on Safeguard Scientifics, Inc.’s Q2 2018 Earnings (SFE)” was first posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/first-analysis-comments-on-safeguard-scientifics-inc-s-q2-2018-earnings-sfe-updated-updated.html.

Safeguard Scientifics (NYSE:SFE) traded down 3.36% during mid-day trading on Monday, reaching $11.50. The company had a trading volume of 16,845 shares. Safeguard Scientifics has a 1-year low of $10.60 and a 1-year high of $14.38. The firm has a 50-day moving average of $11.93 and a 200 day moving average of $12.12. The company’s market capitalization is $234.75 million.

Safeguard Scientifics (NYSE:SFE) last released its earnings results on Thursday, July 27th. The asset manager reported ($1.43) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($1.11) by $0.32. During the same period in the prior year, the company posted $1.92 earnings per share.

Institutional investors have recently made changes to their positions in the stock. KBC Group NV raised its position in shares of Safeguard Scientifics by 47.5% in the first quarter. KBC Group NV now owns 9,447 shares of the asset manager’s stock worth $120,000 after buying an additional 3,044 shares during the last quarter. American International Group Inc. raised its position in shares of Safeguard Scientifics by 7.2% in the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock worth $158,000 after buying an additional 833 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Safeguard Scientifics by 12.9% in the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock worth $195,000 after buying an additional 1,754 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Safeguard Scientifics by 5.2% in the first quarter. Wells Fargo & Company MN now owns 15,951 shares of the asset manager’s stock worth $203,000 after buying an additional 791 shares during the last quarter. Finally, Parametric Portfolio Associates LLC raised its position in shares of Safeguard Scientifics by 58.9% in the first quarter. Parametric Portfolio Associates LLC now owns 16,619 shares of the asset manager’s stock worth $211,000 after buying an additional 6,163 shares during the last quarter. 76.96% of the stock is owned by institutional investors.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply